STOCK TITAN

Venus Concept Inc - VERO STOCK NEWS

Welcome to our dedicated news page for Venus Concept (Ticker: VERO), a resource for investors and traders seeking the latest updates and insights on Venus Concept.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Venus Concept's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Venus Concept's position in the market.

Rhea-AI Summary
Venus Concept Inc. will release its first quarter fiscal year 2024 financial results on May 15, 2024. The company, a global leader in medical aesthetic technology, will host a conference call to discuss the results with a Q&A session. Participants can join via phone or webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.03%
Tags
-
Rhea-AI Summary
Venus Concept Inc. (VERO) receives approval for Venus Bliss MAX in Israel, expanding its global presence. The advanced three-in-one platform offers various treatments for non-invasive lipolysis, muscle relief, cellulite reduction, and muscle conditioning.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.04%
Tags
none
-
Rhea-AI Summary
Venus Concept Inc. (VERO) receives TGA clearance in Australia for Venus Versa Pro system, combining advanced technologies for skin rejuvenation. The company aims to expand its market presence in Australia with a growing direct office.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.87%
Tags
none
Rhea-AI Summary
Venus Concept Inc. (VERO) announced financial results for Q4 and FY 2023. The company reduced cash burn by over 50%, with operating expenses down 20%. Total revenue was $18.1 million, a 25% decrease YoY. Adjusted EBITDA loss was $5.9 million, down 7% YoY. Venus Concept finalized a debt restructuring agreement and received a Nasdaq listing extension. The company is exploring strategic alternatives to maximize shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.75%
Tags
-
Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) receives a decision from the Nasdaq Hearings Panel granting continued listing on the Nasdaq Capital Market, subject to compliance with specific requirements. The company had previously received a deficiency notice for not meeting the minimum stockholders’ equity requirement, leading to a detailed compliance plan and a hearing. Venus Concept is focused on regaining compliance with Nasdaq's listing rules and exploring strategic alternatives to enhance shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.35%
Tags
none
-
Rhea-AI Summary
Venus Concept Inc. launches 'NEXThetics' series to enhance customer education and training, part of the 'Venus Aesthetic Intelligence' rebranding. The events aim to provide networking opportunities for aesthetics industry professionals to share ideas and success stories.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.15%
Tags
none
Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) completes a registered direct offering of 817,748 shares of common stock at $1.465 per share, along with unregistered warrants. The offering, led by H.C. Wainwright & Co., generates approximately $1.2 million in gross proceeds for general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.45%
Tags
-
Rhea-AI Summary
Venus Concept Inc. announces a registered direct offering of 817,748 shares of common stock at $1.465 per share, along with a concurrent private placement of unregistered warrants. The offering is priced at-the-market under Nasdaq rules.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-30.11%
Tags
-
Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) has received the CE Mark for Venus Versa Pro system in the European Union, following the US commercial launch. The system offers advanced skin resurfacing capabilities for various skin conditions. Dr. Hemanth Varghese highlighted the commitment to innovation and international markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
52.46%
Tags
none
Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) to release Q4 and fiscal year 2023 financial results on April 1, 2024. Conference call scheduled for discussion. Webcast available for investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.61%
Tags
Venus Concept Inc

Nasdaq:VERO

VERO Rankings

VERO Stock Data

4.31M
2.57M
8.02%
47.85%
0.44%
Surgical Appliance and Supplies Manufacturing
Manufacturing
Link
Canada
Toronto

About VERO

venus concept is a leader in the global medical aesthetic market, pairing best-in-class technology with the first and only true subscription model in the industry. our goal is to help both new and established practices succeed in this growing field. we understand the challenges of breaking into and being successful in the aesthetics industry, and that’s why we’re changing the game with an innovative solution. the secret is in our industry-unique subscription model. in partnering with venus concept, aesthetic professionals worldwide gain access to never-before-seen business features such as the most comprehensive warranty program, unmatched marketing support, continuous clinical education, valuable practice enhancement programs, and more. together with this business model, our collection of aesthetic systems—including venus versa™, venus legacy™, venus velocity™, venus viva™, venus freeze plus™, and venus skin™—are setting higher industry standards and improving the quality of life for